Please provide your email address to receive an email when new articles are posted on . The FDA today approved the antibiotic meropenem for the treatment of abdominal infections in neonates and ...

image of bacteria Overall treatment success occurred in 98.4% of patients receiving meropenem-vaborbactam vs 94% for those receiving piperacillin-tazobactam. Meropenem-vabobactam, a combination ...

Meropenem has been approved by the Food and Drug Administration (FDA) for the treatment of abdominal infections in infants <3 months old. The approval was based on an open-label, multiple-dose study ...

Please provide your email address to receive an email when new articles are posted on . WASHINGTON — Cefiderocol, a novel siderophore cephalosporin, was noninferior to high-dose meropenem for the ...

Bacterial blood infection, computer illustration. Researchers compared outcomes of continuous vs intermittent meropenem among critically ill patients with sepsis. Clinical outcomes among critically ...

Purpose: The stability of meropenem in i.v. solutions stored in polyvinyl chloride (PVC) bags and an elastomeric infusion device at concentrations commonly used in home care was studied. Methods: ...